Tag Archives: KR

Analysts’ View: Kroger (KR), Deutsche Bank (DB), Inovalon (INOV)

Investment Analysts at Pivotal Research Group upgraded Kroger Co. (NYSE:KR) shares from Hold to Buy rating.

The Kroger Co. engages in the operation of retail food and drug stores, multi-department stores, jewelry stores, and convenience stores.

*

Brokerage Firm Keefe Bruyette upgraded Deutsche Bank AG (NYSE:DB) shares from Market Perform to Outperform rating.

Deutsche Bank AG engages in the provision of corporate banking and investment services.

*

Inovalon Holdings, Inc. (NASDAQ:INOV) shares were upgraded by analysts at Morgan Stanley from Underweight to Equal-Weight rating.

Inovalon Holdings, Inc. engages in the provision of cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ Perspective: Cloud Peak Energy (CLD), Kroger (KR), Supervalu (SVU)

Investment Analysts at FBR & Co. upgraded Cloud Peak Energy Inc. (NYSE:CLD) shares from Underperform to Mkt Perform rating with a price target of $4.

Cloud Peak Energy Inc. produces coal in the Powder River Basin in the United States.

*

Brokerage Firm RBC Capital Mkts upgraded The Kroger Co. (NYSE:KR) shares from Sector Perform to Outperform rating with a price target of $37.

The Kroger Co., together with its subsidiaries, operates as a retailer in the United States.

*

SUPERVALU Inc. (NYSE:SVU) shares were upgraded by analysts at RBC Capital Mkts from Sector Perform to Outperform rating with a price target of $6.

SUPERVALU INC., together with its subsidiaries, operates as a grocery wholesaler and retailer in the United States.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ Perspective: Kroger (KR), SAGE Therapeutics (SAGE), Henkel AG (HENKY)

Investment Analysts at Piper Jaffray upgraded The Kroger Co. (NYSE:KR) shares from Underweight to Neutral rating while increasing their price target from $28 to $34.

The Kroger Co., together with its subsidiaries, operates as a retailer in the United States.

*

Brokerage Firm Raymond James upgraded Sage Therapeutics, Inc. (NASDAQ:SAGE) shares from Outperform to Strong Buy rating with a price target of $84.

Sage Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel medicines to treat central nervous system disorders.

*

Henkel AG & Co. KGaA (OTCMKTS:HENKY) shares were upgraded by analysts at Raymond James from Outperform to Strong Buy rating.

Henkel AG & Co. KGaA, together with its subsidiaries, engages in laundry and home care, beauty care, and adhesive technology businesses worldwide.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/